Australia's largest stock trading and investment forum Australia's #1 stock forum

WFL

0.00%

0.3¢ wellfully limited

Ann: Appendix 4C June 2019 Quarter, page-6

First 6 Last

Share
Profile

Follow
objforever

1,525 Posts.

213

31/07/19

18:41

Post #: 39794425
Share

Originally posted by Westhx ↑

I own too many of these (over 3 mil) having doubled my holdings at 5.5 cents and again at 3 cents. What can I say except the obvious. The receipts from p&g are not enough to avoid a capital raising for Obj's in house products. Just 2.2 mil left. Denison also mislead me with regard to the 7 figure up front payment for the second tech.

P&G still doesn't even cover the admin and corporate costs.

The shareholder update barely mentions p&g.

With a CR now a certainty to fund bodyguard and little green venture you have to ask how low and how much dilution. we have enough cash for two more quarters.

I invested in obj because of p&g and that has proven to be a disaster. yet I don't see bodyguard or a cannabis patch as big earners. That just leaves Obj in-house products that may actually compete with p&g. How will these be marketed?

Do I wait for product development updates re p&g? We need certainty that much higher revenues are forthcoming from p&g.

I anticipate a CR sub one cent within a couple of months if things keep tracking as they are.

Directors should start buying in large quantities. the person who dumped 3.5 mil shared yesterday is probably feeling relieved as I can't see how this stock tracks higher from here.

Unsure whether to hold anymore. The capital loss will be extreme.

Expand

Don't worry dude...some group will somehow for God knows why will pump the spare to 4c or 5c so a cr can be at higher price.....Hahaha what a joke

OBJ Price at posting: 1.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 1 more message in this thread...

First 6 Last

Add WFL (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $1.478M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Appendix 4C June 2019 Quarter, page-6

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News

Ann: Appendix 4C June 2019 Quarter, page-6

Top Stories

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Featured News